Map2k6 Rat (-)-alpha-phellandrene increases expression ISO MAP2K6 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of MAP2K6 mRNA CTD PMID:25075043 Map2k6 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 Map2k6 Rat (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of MAP2K6 mRNA CTD PMID:20426880 Map2k6 Rat 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 o and p'-DDT promotes the reaction [MAP2K6 protein results in increased activity of CREBBP protein] CTD PMID:22609851 Map2k6 Rat 1,2-dimethylhydrazine decreases expression ISO Map2k6 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MAP2K6 mRNA CTD PMID:22206623 Map2k6 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:15834898 Map2k6 Rat 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAP2K6 mRNA CTD PMID:26865667 Map2k6 Rat 17beta-estradiol multiple interactions ISO Map2k6 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of MAP2K6 mRNA] CTD PMID:25210133 Map2k6 Rat 17beta-estradiol decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:31614463 Map2k6 Rat 17beta-estradiol multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP2K6 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA CTD PMID:17404688 and PMID:30165855 Map2k6 Rat 17beta-estradiol decreases expression ISO Map2k6 (Mus musculus) 6480464 Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:25210133 Map2k6 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Map2k6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP2K6 mRNA CTD PMID:14708085 Map2k6 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO MAP2K6 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K6 mRNA CTD PMID:22574217 Map2k6 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map2k6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K6 mRNA CTD PMID:21570461 and PMID:28922406 Map2k6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP2K6 mRNA CTD PMID:21215274 and PMID:33387578 Map2k6 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MAP2K6 mRNA] CTD PMID:21215274 Map2k6 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO MAP2K6 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 Map2k6 Rat 2-nitrofluorene decreases expression EXP 6480464 2-nitrofluorene results in decreased expression of MAP2K6 mRNA CTD PMID:22484513 Map2k6 Rat 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Map2k6 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 Map2k6 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Map2k6 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP2K6 mRNA CTD PMID:26251327 Map2k6 Rat 3,4-methylenedioxymethamphetamine increases methylation ISO Map2k6 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of MAP2K6 promoter CTD PMID:26251327 Map2k6 Rat 4,4'-diaminodiphenylmethane increases expression ISO Map2k6 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of MAP2K6 mRNA CTD PMID:18648102 Map2k6 Rat 4-hydroxyphenyl retinamide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] CTD PMID:16407847 Map2k6 Rat 4-hydroxyphenyl retinamide increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Fenretinide results in increased phosphorylation of MAP2K6 protein CTD PMID:16407847 Map2k6 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAP2K6 mRNA CTD PMID:30047161 Map2k6 Rat afimoxifene decreases response to substance ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 results in decreased susceptibility to afimoxifene CTD PMID:21233418 Map2k6 Rat aflatoxin B1 affects expression ISO MAP2K6 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MAP2K6 protein CTD PMID:20106945 Map2k6 Rat aflatoxin B1 decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MAP2K6 mRNA CTD PMID:21632981 more ... Map2k6 Rat aflatoxin B1 increases methylation ISO MAP2K6 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of MAP2K6 gene CTD PMID:27153756 Map2k6 Rat aldehydo-D-glucose multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 Map2k6 Rat all-trans-retinoic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP2K6 mRNA CTD PMID:21934132 Map2k6 Rat all-trans-retinoic acid increases expression ISO MAP2K6 (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP2K6 mRNA CTD PMID:33167477 Map2k6 Rat alpha-phellandrene increases expression ISO MAP2K6 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of MAP2K6 mRNA CTD PMID:25075043 Map2k6 Rat amino acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Amino Acids CTD PMID:27278863 Map2k6 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP2K6 mRNA CTD PMID:16483693 Map2k6 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MAP2K6 mRNA CTD PMID:30779732 Map2k6 Rat andrographolide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein] CTD PMID:24814888 Map2k6 Rat anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [[MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] CTD PMID:27278863 Map2k6 Rat antirheumatic drug increases expression ISO MAP2K6 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MAP2K6 mRNA CTD PMID:24449571 Map2k6 Rat aristolochic acid A decreases expression ISO MAP2K6 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAP2K6 mRNA CTD PMID:33212167 Map2k6 Rat arsane affects methylation ISO MAP2K6 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP2K6 gene CTD PMID:25304211 Map2k6 Rat arsane decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic results in decreased expression of MAP2K6 mRNA CTD PMID:29248574 Map2k6 Rat arsenic atom affects methylation ISO MAP2K6 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP2K6 gene CTD PMID:25304211 Map2k6 Rat arsenic atom decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic results in decreased expression of MAP2K6 mRNA CTD PMID:29248574 Map2k6 Rat arsenite(3-) increases expression ISO Map2k6 (Mus musculus) 6480464 arsenite results in increased expression of MAP2K6 mRNA CTD PMID:18191166 Map2k6 Rat arsenous acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MAP2K6 mRNA CTD PMID:26705709 Map2k6 Rat arsenous acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein CTD PMID:16818652 Map2k6 Rat arsenous acid multiple interactions ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 Map2k6 Rat arsenous acid affects response to substance ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 Map2k6 Rat atazanavir sulfate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 Map2k6 Rat atazanavir sulfate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 Map2k6 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MAP2K6 gene CTD PMID:28931070 Map2k6 Rat azathioprine decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Azathioprine results in decreased expression of MAP2K6 mRNA CTD PMID:22623647 Map2k6 Rat benzene decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Benzene results in decreased expression of MAP2K6 mRNA CTD PMID:33064461 Map2k6 Rat benzene increases expression ISO Map2k6 (Mus musculus) 6480464 Benzene results in increased expression of MAP2K6 mRNA CTD PMID:34624356 Map2k6 Rat benzo[a]pyrene decreases expression ISO Map2k6 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA CTD PMID:19770486 and PMID:21569818 Map2k6 Rat benzo[a]pyrene decreases methylation ISO Map2k6 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of MAP2K6 intron CTD PMID:27901495 Map2k6 Rat benzo[a]pyrene decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA CTD PMID:20106945 more ... Map2k6 Rat benzo[a]pyrene affects expression ISO MAP2K6 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of MAP2K6 mRNA CTD PMID:21714911 Map2k6 Rat beta-D-glucan decreases expression ISO MAP2K6 (Homo sapiens) 6480464 beta-Glucans results in decreased expression of MAP2K6 mRNA CTD PMID:25970150 Map2k6 Rat bis(2-chloroethyl) sulfide increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Mustard Gas results in increased phosphorylation of MAP2K6 protein CTD PMID:15251176 Map2k6 Rat bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of MAP2K6 mRNA CTD PMID:15651846 Map2k6 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Map2k6 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:19850644 Map2k6 Rat bis(2-ethylhexyl) phthalate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:31163220 Map2k6 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Map2k6 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA] CTD PMID:19850644 Map2k6 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP2K6 mRNA CTD PMID:25181051 Map2k6 Rat bisphenol A multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAP2K6 gene CTD PMID:31601247 Map2k6 Rat bortezomib decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Bortezomib results in decreased expression of MAP2K6 mRNA CTD PMID:20977926 Map2k6 Rat bromoacetate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 bromoacetate results in decreased expression of MAP2K6 mRNA CTD PMID:19753638 Map2k6 Rat cadmium dichloride multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA and Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:12634122 and PMID:18703135 Map2k6 Rat cadmium dichloride increases expression ISO MAP2K6 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP2K6 mRNA CTD PMID:32512071 Map2k6 Rat cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K6 protein CTD PMID:18021293 and PMID:18703135 Map2k6 Rat cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 Map2k6 Rat cadmium dichloride increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K6 protein CTD PMID:18703135 Map2k6 Rat cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of MAP2K6 gene CTD PMID:30521419 Map2k6 Rat carbamazepine affects expression ISO MAP2K6 (Homo sapiens) 6480464 Carbamazepine affects the expression of MAP2K6 mRNA CTD PMID:24752500 Map2k6 Rat carbon nanotube decreases expression ISO Map2k6 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of MAP2K6 mRNA CTD PMID:25554681 and PMID:25620056 Map2k6 Rat CGP 52608 multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP2K6 gene] CTD PMID:28238834 Map2k6 Rat chenodeoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 Map2k6 Rat cisplatin affects response to substance ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein affects the susceptibility to Cisplatin CTD PMID:16217747 Map2k6 Rat cisplatin increases expression ISO MAP2K6 (Homo sapiens) 6480464 Cisplatin results in increased expression of MAP2K6 mRNA CTD PMID:27392435 Map2k6 Rat cisplatin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of MAP2K6 mRNA] and jinfukang promotes the reaction [Cisplatin results in increased expression of MAP2K6 mRNA] CTD PMID:27392435 Map2k6 Rat cisplatin multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of MAP2K6 mRNA] CTD PMID:23558232 Map2k6 Rat cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP2K6 mRNA CTD PMID:23558232 Map2k6 Rat cisplatin decreases response to substance EXP 6480464 MAP2K6 protein results in decreased susceptibility to Cisplatin CTD PMID:19578154 Map2k6 Rat copper atom multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP2K6 mRNA more ... CTD PMID:20971185 more ... Map2k6 Rat copper(0) multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP2K6 mRNA more ... CTD PMID:20971185 more ... Map2k6 Rat copper(II) sulfate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of MAP2K6 mRNA CTD PMID:19549813 Map2k6 Rat corn oil affects expression EXP 6480464 Corn Oil affects the expression of MAP2K6 mRNA CTD PMID:16360708 Map2k6 Rat crocidolite asbestos decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of MAP2K6 mRNA CTD PMID:18687144 Map2k6 Rat cyclosporin A decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MAP2K6 mRNA CTD PMID:20106945 more ... Map2k6 Rat cyclosporin A multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 Map2k6 Rat cyclosporin A increases expression ISO MAP2K6 (Homo sapiens) 6480464 Cyclosporine results in increased expression of MAP2K6 mRNA CTD PMID:27989131 Map2k6 Rat D-glucose multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 Map2k6 Rat DDT multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein promotes the reaction [DDT results in increased activity of NOTCH1 protein] CTD PMID:18791200 Map2k6 Rat deoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 Map2k6 Rat deoxynivalenol multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K6 protein] CTD PMID:20181660 Map2k6 Rat deoxynivalenol increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 deoxynivalenol results in increased phosphorylation of MAP2K6 protein CTD PMID:20181660 Map2k6 Rat dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MAP2K6 mRNA CTD PMID:20032058 Map2k6 Rat dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAP2K6 mRNA] CTD PMID:20032058 Map2k6 Rat diarsenic trioxide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein CTD PMID:16818652 Map2k6 Rat diarsenic trioxide multiple interactions ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 Map2k6 Rat diarsenic trioxide decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MAP2K6 mRNA CTD PMID:26705709 Map2k6 Rat diarsenic trioxide affects response to substance ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 Map2k6 Rat dibenz[a,h]anthracene increases expression ISO Map2k6 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Map2k6 Rat dibutyl phthalate decreases expression ISO Map2k6 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:21266533 Map2k6 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:21266533 Map2k6 Rat dichloroacetic acid decreases expression ISO Map2k6 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:28962523 Map2k6 Rat dichromium trioxide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 Map2k6 Rat diclofenac affects expression ISO MAP2K6 (Homo sapiens) 6480464 Diclofenac affects the expression of MAP2K6 mRNA CTD PMID:24752500 Map2k6 Rat dicrotophos decreases expression ISO MAP2K6 (Homo sapiens) 6480464 dicrotophos results in decreased expression of MAP2K6 mRNA CTD PMID:28302478 Map2k6 Rat Didecyldimethylammonium decreases expression ISO MAP2K6 (Homo sapiens) 6480464 didecyldimethylammonium results in decreased expression of MAP2K6 mRNA CTD PMID:32763356 Map2k6 Rat disodium selenite decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of MAP2K6 mRNA CTD PMID:16705456 Map2k6 Rat disodium selenite increases expression ISO MAP2K6 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of MAP2K6 mRNA CTD PMID:18175754 Map2k6 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of MAP2K6 mRNA CTD PMID:21551480 Map2k6 Rat dorsomorphin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Map2k6 Rat doxorubicin affects activity ISO MAP2K6 (Homo sapiens) 6480464 Doxorubicin affects the activity of MAP2K6 protein CTD PMID:15870702 Map2k6 Rat doxorubicin affects methylation EXP 6480464 Doxorubicin affects the methylation of MAP2K6 gene CTD PMID:28962528 Map2k6 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP2K6 mRNA CTD PMID:29391264 Map2k6 Rat entinostat decreases expression ISO MAP2K6 (Homo sapiens) 6480464 entinostat results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 Map2k6 Rat epoxiconazole decreases expression ISO Map2k6 (Mus musculus) 6480464 epoxiconazole results in decreased expression of MAP2K6 mRNA CTD PMID:35436446 Map2k6 Rat ethanol affects expression ISO Map2k6 (Mus musculus) 6480464 Ethanol affects the expression of MAP2K6 mRNA CTD PMID:30319688 Map2k6 Rat filipin III multiple interactions EXP 6480464 Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 Map2k6 Rat folic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Folic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:21867686 Map2k6 Rat FR900359 increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of MAP2K6 protein CTD PMID:37730182 Map2k6 Rat fulvestrant multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAP2K6 gene and MAP2K6 promotes the reaction [Fulvestrant results in decreased expression of GJA1 protein] CTD PMID:29180066 and PMID:31601247 Map2k6 Rat gemcitabine increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Gemcitabine results in increased phosphorylation of MAP2K6 protein CTD PMID:15003513 Map2k6 Rat genistein decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Genistein results in decreased expression of MAP2K6 mRNA CTD PMID:26865667 Map2k6 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP2K6 mRNA CTD PMID:33387578 Map2k6 Rat glucose multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 Map2k6 Rat glycochenodeoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 Map2k6 Rat glycocholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 Map2k6 Rat glycodeoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 Map2k6 Rat glyphosate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Glyphosate results in decreased expression of MAP2K6 mRNA CTD PMID:31295307 Map2k6 Rat hydrogen peroxide affects expression ISO MAP2K6 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of MAP2K6 mRNA CTD PMID:20044591 Map2k6 Rat iron atom multiple interactions EXP 6480464 Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 Map2k6 Rat iron atom increases phosphorylation EXP 6480464 Iron results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 Map2k6 Rat iron dichloride decreases expression ISO MAP2K6 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of MAP2K6 mRNA CTD PMID:35984750 Map2k6 Rat iron(0) multiple interactions EXP 6480464 Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 Map2k6 Rat iron(0) increases phosphorylation EXP 6480464 Iron results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 Map2k6 Rat iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein] more ... CTD PMID:17172471 Map2k6 Rat iron(2+) sulfate (anhydrous) increases phosphorylation EXP 6480464 ferrous sulfate results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 Map2k6 Rat L-ascorbic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] CTD PMID:16407847 Map2k6 Rat lead diacetate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 Map2k6 Rat lipopolysaccharide multiple interactions ISO Map2k6 (Mus musculus) 6480464 IRAK2 protein promotes the reaction [Lipopolysaccharides results in increased activity of MAP2K6 protein] CTD PMID:21291324 Map2k6 Rat lipopolysaccharide increases activity ISO Map2k6 (Mus musculus) 6480464 Lipopolysaccharides results in increased activity of MAP2K6 protein CTD PMID:21291324 Map2k6 Rat lycopene decreases expression ISO MAP2K6 (Homo sapiens) 6480464 lycopene results in decreased expression of MAP2K6 protein CTD PMID:17337101 Map2k6 Rat maneb multiple interactions ISO Map2k6 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA more ... CTD PMID:23963992 Map2k6 Rat melatonin multiple interactions ISO Map2k6 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA] CTD PMID:23963992 Map2k6 Rat mercury dibromide decreases expression ISO MAP2K6 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 Map2k6 Rat mercury dibromide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat mercury dichloride decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of MAP2K6 mRNA CTD PMID:30047161 Map2k6 Rat methotrexate affects response to substance ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein affects the susceptibility to Methotrexate CTD PMID:16217747 Map2k6 Rat methotrexate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Methotrexate results in decreased expression of MAP2K6 mRNA CTD PMID:19100307 Map2k6 Rat methylmercury chloride decreases expression ISO MAP2K6 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 and PMID:28001369 Map2k6 Rat mevinphos increases phosphorylation EXP 6480464 Mevinphos results in increased phosphorylation of MAP2K6 protein CTD PMID:23157661 Map2k6 Rat mono(2-ethylhexyl) phthalate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:36695872 Map2k6 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MAP2K6 gene CTD PMID:33148267 Map2k6 Rat N-acetyl-L-cysteine multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 Map2k6 Rat N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 Map2k6 Rat N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 CIB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP2K6 protein] CTD PMID:28939911 Map2k6 Rat N-methyl-4-phenylpyridinium increases phosphorylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP2K6 protein CTD PMID:28939911 Map2k6 Rat nefazodone multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 Map2k6 Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAP2K6 mRNA CTD PMID:22110744 Map2k6 Rat nickel dichloride increases response to substance ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein results in increased susceptibility to nickel chloride CTD PMID:21544193 Map2k6 Rat nickel dichloride multiple interactions ISO Map2k6 (Mus musculus) 6480464 [incomplete Freund's adjuvant co-treated with Freund's Adjuvant co-treated with nickel chloride] results in increased expression of MAP2K6 mRNA more ... CTD PMID:21544193 and PMID:23536762 Map2k6 Rat nicotine increases expression EXP 6480464 Nicotine results in increased expression of MAP2K6 mRNA CTD PMID:20426880 Map2k6 Rat Nonylphenol increases expression ISO MAP2K6 (Homo sapiens) 6480464 nonylphenol results in increased expression of MAP2K6 protein CTD PMID:24039973 Map2k6 Rat obeticholic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of MAP2K6 mRNA CTD PMID:27939613 Map2k6 Rat organoselenium compound multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA CTD PMID:25167922 Map2k6 Rat ouabain increases expression ISO MAP2K6 (Homo sapiens) 6480464 Ouabain results in increased expression of MAP2K6 mRNA CTD PMID:28795476 Map2k6 Rat ozone multiple interactions ISO Map2k6 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP2K6 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAP2K6 mRNA CTD PMID:34911549 Map2k6 Rat p-chloromercuribenzoic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 Map2k6 Rat p-chloromercuribenzoic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat p-menthan-3-ol decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Menthol results in decreased expression of MAP2K6 mRNA CTD PMID:26760959 Map2k6 Rat panobinostat multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat paracetamol affects expression ISO Map2k6 (Mus musculus) 6480464 Acetaminophen affects the expression of MAP2K6 mRNA CTD PMID:17562736 Map2k6 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MAP2K6 mRNA CTD PMID:33387578 Map2k6 Rat paracetamol multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 Map2k6 Rat paracetamol decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of MAP2K6 mRNA CTD PMID:29067470 Map2k6 Rat paraquat multiple interactions ISO Map2k6 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA more ... CTD PMID:23963992 Map2k6 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of MAP2K6 mRNA CTD PMID:32680482 Map2k6 Rat parathion increases expression ISO Map2k6 (Mus musculus) 6480464 Parathion results in increased expression of MAP2K6 mRNA CTD PMID:34813904 Map2k6 Rat perfluorohexanesulfonic acid decreases expression ISO Map2k6 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of MAP2K6 mRNA CTD PMID:37995155 Map2k6 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MAP2K6 gene CTD PMID:33148267 Map2k6 Rat phenobarbital increases expression ISO Map2k6 (Mus musculus) 6480464 Phenobarbital results in increased expression of MAP2K6 mRNA CTD PMID:19270015 Map2k6 Rat phenobarbital affects expression ISO Map2k6 (Mus musculus) 6480464 Phenobarbital affects the expression of MAP2K6 mRNA CTD PMID:23091169 Map2k6 Rat phenylmercury acetate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 Map2k6 Rat phenylmercury acetate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat phlorizin increases expression ISO Map2k6 (Mus musculus) 6480464 Phlorhizin results in increased expression of MAP2K6 mRNA CTD PMID:22538082 Map2k6 Rat phorbol 13-acetate 12-myristate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate more ... CTD PMID:27278863 Map2k6 Rat piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of MAP2K6 mRNA CTD PMID:22484513 Map2k6 Rat pirinixic acid multiple interactions ISO Map2k6 (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of MAP2K6 mRNA CTD PMID:20813756 Map2k6 Rat pirinixic acid decreases expression ISO Map2k6 (Mus musculus) 6480464 pirinixic acid results in decreased expression of MAP2K6 mRNA CTD PMID:20813756 and PMID:23811191 Map2k6 Rat potassium chromate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 Map2k6 Rat potassium chromate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 Map2k6 Rat progesterone multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA CTD PMID:17404688 Map2k6 Rat progesterone increases expression ISO MAP2K6 (Homo sapiens) 6480464 Progesterone results in increased expression of MAP2K6 mRNA CTD PMID:17404688 Map2k6 Rat Ptaquiloside decreases expression ISO MAP2K6 (Homo sapiens) 6480464 ptaquiloside results in decreased expression of MAP2K6 mRNA CTD PMID:22143989 Map2k6 Rat quercetin increases expression ISO MAP2K6 (Homo sapiens) 6480464 Quercetin results in increased expression of MAP2K6 mRNA CTD PMID:27514524 Map2k6 Rat quercetin decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Quercetin results in decreased expression of MAP2K6 mRNA CTD PMID:21632981 Map2k6 Rat raloxifene multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein promotes the reaction [Raloxifene Hydrochloride results in increased expression of HMOX1 protein] CTD PMID:20888885 Map2k6 Rat ritodrine increases expression ISO Map2k6 (Mus musculus) 6480464 Ritodrine results in increased expression of MAP2K6 mRNA CTD PMID:23370008 Map2k6 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAP2K6 mRNA CTD PMID:28374803 Map2k6 Rat S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO MAP2K6 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of MAP2K6 mRNA CTD PMID:33725128 Map2k6 Rat Salinomycin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA] and [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein] CTD PMID:30796972 Map2k6 Rat SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] CTD PMID:15767673 Map2k6 Rat SB 203580 multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 SB 203580 inhibits the reaction [[MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] CTD PMID:27278863 Map2k6 Rat SB 431542 multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Map2k6 Rat Securinine decreases expression ISO MAP2K6 (Homo sapiens) 6480464 securinine results in decreased expression of MAP2K6 mRNA CTD PMID:32662633 Map2k6 Rat sevoflurane increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 sevoflurane results in increased phosphorylation of MAP2K6 protein CTD PMID:18349187 Map2k6 Rat silicon dioxide decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of MAP2K6 mRNA and Silicon Dioxide results in decreased expression of MAP2K6 mRNA CTD PMID:22300531 and PMID:25895662 Map2k6 Rat sodium arsenite multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:12634122 and PMID:9442025 Map2k6 Rat sodium arsenite increases expression ISO MAP2K6 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP2K6 mRNA CTD PMID:17879257 Map2k6 Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MAP2K6 mRNA CTD PMID:22110744 Map2k6 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of MAP2K6 mRNA CTD PMID:19281266 Map2k6 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of MAP2K6 mRNA CTD PMID:25905778 Map2k6 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of MAP2K6 mRNA CTD PMID:30047161 Map2k6 Rat sulfates multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Soot co-treated with Sulfates] affects the methylation of MAP2K6 promoter CTD PMID:25395096 Map2k6 Rat sulforaphane decreases expression ISO MAP2K6 (Homo sapiens) 6480464 sulforaphane results in decreased expression of MAP2K6 mRNA CTD PMID:26833863 and PMID:31838189 Map2k6 Rat Sunset Yellow FCF multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of MAP2K6 mRNA CTD PMID:33819548 Map2k6 Rat tanespimycin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA] and [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein] CTD PMID:30796972 Map2k6 Rat tartrazine multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 Map2k6 Rat tert-butyl hydroperoxide increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein CTD PMID:17003459 Map2k6 Rat testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAP2K6 mRNA] CTD PMID:20032058 Map2k6 Rat tetrachloromethane decreases expression ISO Map2k6 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of MAP2K6 mRNA CTD PMID:31919559 Map2k6 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MAP2K6 mRNA CTD PMID:23411599 and PMID:34492290 Map2k6 Rat thiram decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Thiram results in decreased expression of MAP2K6 mRNA CTD PMID:38568856 Map2k6 Rat trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of MAP2K6 mRNA CTD PMID:23558232 Map2k6 Rat trichostatin A multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat trichostatin A decreases expression ISO MAP2K6 (Homo sapiens) 6480464 trichostatin A results in decreased expression of MAP2K6 mRNA CTD PMID:24935251 and PMID:26272509 Map2k6 Rat trichostatin A increases expression ISO MAP2K6 (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP2K6 mRNA CTD PMID:24935251 Map2k6 Rat trichostatin A multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of MAP2K6 mRNA] CTD PMID:23558232 Map2k6 Rat triclosan multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 Map2k6 Rat trimethyltin decreases expression ISO Map2k6 (Mus musculus) 6480464 trimethyltin results in decreased expression of MAP2K6 mRNA CTD PMID:21435392 Map2k6 Rat Triptolide decreases expression ISO Map2k6 (Mus musculus) 6480464 triptolide results in decreased expression of MAP2K6 mRNA CTD PMID:32835833 Map2k6 Rat tris(2-butoxyethyl) phosphate affects expression ISO MAP2K6 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of MAP2K6 mRNA CTD PMID:29024780 Map2k6 Rat troglitazone decreases expression ISO MAP2K6 (Homo sapiens) 6480464 troglitazone results in decreased expression of MAP2K6 mRNA CTD PMID:19140230 Map2k6 Rat trovafloxacin decreases expression ISO Map2k6 (Mus musculus) 6480464 trovafloxacin results in decreased expression of MAP2K6 mRNA CTD PMID:35537566 Map2k6 Rat urethane decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Urethane results in decreased expression of MAP2K6 mRNA CTD PMID:28818685 Map2k6 Rat valproic acid increases expression ISO MAP2K6 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP2K6 mRNA CTD PMID:24935251 and PMID:29154799 Map2k6 Rat valproic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 Map2k6 Rat valproic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:23179753 more ... Map2k6 Rat vanadium atom increases expression ISO MAP2K6 (Homo sapiens) 6480464 Vanadium results in increased expression of MAP2K6 mRNA CTD PMID:19000753 Map2k6 Rat vanadium(0) increases expression ISO MAP2K6 (Homo sapiens) 6480464 Vanadium results in increased expression of MAP2K6 mRNA CTD PMID:19000753